SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000909661-17-000018
Filing Date
2017-08-08
Accepted
2017-08-08 17:14:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 NEXVET BIOPHARMA PLC 13D/A2 nexvet13d-a2.htm SC 13D/A 418706
  Complete submission text file 0000909661-17-000018.txt   420484
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Subject) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88634 | Film No.: 171015665
SIC: 2834 Pharmaceutical Preparations